These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Bovine viral diarrhea virus types 1 and 2 antibody response in calves receiving modified live virus or inactivated vaccines. Fulton RW; Burge LJ Vaccine; 2000 Sep; 19(2-3):264-74. PubMed ID: 10930681 [TBL] [Abstract][Full Text] [Related]
67. A study of the effectiveness of a needle-free injection device compared with a needle and syringe used to vaccinate calves against bovine viral diarrhea and infectious bovine rhinotracheitis viruses. Rey MR; Undi M; Rodriguez-Lecompte JC; Joseph T; Morrison J; Yitbarek A; Wittenberg K; Tremblay R; Crow GH; Ominski KH Vet J; 2013 Oct; 198(1):235-8. PubMed ID: 24011475 [TBL] [Abstract][Full Text] [Related]
68. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine. Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238 [TBL] [Abstract][Full Text] [Related]
69. A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge. Bruschke CJ; Moormann RJ; van Oirschot JT; van Rijn PA Vaccine; 1997 Dec; 15(17-18):1940-5. PubMed ID: 9413105 [TBL] [Abstract][Full Text] [Related]
70. Serological response of guinea pigs to oily and aqueous inactivated vaccines containing a Brazilian isolate of the Bovine Viral Diarrhea Virus (BVDV). Jordão RS; Ribeiro CP; Pituco EM; Okuda LH; Del Fava C; Stefano Ed; Filho MM; Mehnert DU Res Vet Sci; 2011 Oct; 91(2):311-5. PubMed ID: 21316721 [TBL] [Abstract][Full Text] [Related]
71. Prevalence of cattle persistently infected with bovine viral diarrhea virus in 20 dairy herds in two counties in central Michigan and comparison of prevalence of antibody-positive cattle among herds with different infection and vaccination status. Houe H; Baker JC; Maes RK; Wuryastuti H; Wasito R; Ruegg PL; Lloyd JW J Vet Diagn Invest; 1995 Jul; 7(3):321-6. PubMed ID: 7578445 [TBL] [Abstract][Full Text] [Related]
72. Recombinant polypeptide from the gp48 region of the bovine viral diarrhea virus (BVDV) detects serum antibodies in vaccinated and infected cattle. Kwang J; Littledike ET; Donis RO; Dubovi EJ Vet Microbiol; 1992 Oct; 32(3-4):281-92. PubMed ID: 1333674 [TBL] [Abstract][Full Text] [Related]
74. Efficacy of bovine viral diarrhea vaccine used in Japan against bovine viral diarrhea virus type 2 strain 890. Shimazaki T; Nakamura S; Taguchi K; Inoue Y J Vet Med Sci; 2003 Feb; 65(2):263-6. PubMed ID: 12655125 [TBL] [Abstract][Full Text] [Related]
75. Role of bovine viral diarrhea virus biotype in the establishment of fetal infections. Harding MJ; Cao X; Shams H; Johnson AF; Vassilev VB; Gil LH; Wheeler DW; Haines D; Sibert GJ; Nelson LD; Campos M; Donis RO Am J Vet Res; 2002 Oct; 63(10):1455-63. PubMed ID: 12375578 [TBL] [Abstract][Full Text] [Related]
76. Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains. Xue W; Mattick D; Smith L; Umbaugh J; Trigo E Vaccine; 2010 Dec; 29(1):70-6. PubMed ID: 21034829 [TBL] [Abstract][Full Text] [Related]
77. Fetal protection against bovine viral diarrhoea type 1 virus infection after one administration of a live-attenuated vaccine. Meyer G; Deplanche M; Roux D; Moulignie M; Picard-Hagen N; Lyazrhi F; Raboisson D; Mathevet P; Schelcher F Vet J; 2012 May; 192(2):242-5. PubMed ID: 21689959 [TBL] [Abstract][Full Text] [Related]
78. Foetal cross-protection experiments between type 1 and type 2 bovine viral diarrhoea virus in pregnant ewes. Paton DJ; Sharp G; Ibata G Vet Microbiol; 1999 Jan; 64(2-3):185-96. PubMed ID: 10028172 [TBL] [Abstract][Full Text] [Related]